IRUS Total

What is the best drug to treat COVID-19? The need for randomized controlled trials

File Description SizeFormat 
MEDJ2.pdfAccepted version65.89 kBAdobe PDFView/Open
Title: What is the best drug to treat COVID-19? The need for randomized controlled trials
Authors: Ottaviani, S
Stebbing, J
Item Type: Journal Article
Abstract: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the biggest public health challenge to the biomedical community of the last century. Despite multiple public health measures,1, 2, 3 there remains an urgent need for pharmacologic therapies to treat infected patients, minimize mortality, and decrease pressures on intensive care units and health systems and optimally, they should also decrease subsequent transmission.
Issue Date: 18-Dec-2020
Date of Acceptance: 20-Apr-2020
URI: http://hdl.handle.net/10044/1/78454
DOI: 10.1016/j.medj.2020.04.002
ISSN: 1357-3039
Publisher: Elsevier
Start Page: 9
End Page: 10
Journal / Book Title: Medicine
Volume: 1
Issue: 1
Copyright Statement: © 2020 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Sponsor/Funder: National Institute for Health Research
Funder's Grant Number: NIHR-RP-011-053
Keywords: 1103 Clinical Sciences
Arthritis & Rheumatology
Publication Status: Published
Online Publication Date: 2020-05-19
Appears in Collections:Department of Surgery and Cancer
Faculty of Medicine
Imperial College London COVID-19